natgillin/translations-raw huggingface dataset:
Office for Official Publications of the European Communities νητ όπα ιατνεθίταιδ ςαδίρε ηφΕ ςη ησίπΕ: ςητ απυτίτνα ιακ ςώθακ ςέτυα ςιεσόδκε ιΟ ησωνΈ ήκϊαπωρυΕ νητσ ατνόϊορπ άκιτυεκα ραφ ατ. νυοπέιδ υοπ ςενόνακ ιΟ άριεσ ητσ ςησίπε νυοχράπυ νωεξάταιδ νωλλά ιακ ωνάπαραπ νωτ ανε ίεκ αΤ
1) • Council Regulation (EEC) No 2377/ 90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as amended (OJ L 224, 18.8.1990, p.
σ
1)
1)
62 EMEA General Report 2000
νώκιλετ νωτ νωνέ οναβ αλιρεπ υσ
• Council Directive 75/ 319/ EEC of 20 May 1975 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products, as amended (OJ L 147, 9.6.1975, p.
υοτ νώναπαδ ιακ νωδόσε ςό σιγολοσΙ ςητ ΕΕ ακα ράφ άναφρο
13) • Council Directive 81/ 851/ EEC of 28 September 1981 on the approximation of the laws of Member States relating to veterinary medicinal products, as amended (OJ L 317, 6.11.1981, p.
υοίρβ εκε∆ ςη ςητ υοίλυοβ υΣ υοτ ιακ υοίλυοβονιοΚ ύοκϊαπωρυΕ υοτ
1) • Council Regulation (EC) No 2743/ 98 of 14 December 1998 amending Council Regulation (EC) No 297/ 95 on fees payable to the European Agency for the Evaluation of Medicinal Products (OJ L 345, 19.12.1998, p.
16
3) • European Parliament and Council Regulation (EC) No 141/ 2000 of 16 December 1999 on orphan medicinal products (OJ L 18, 22.1.2000, p.
νωκά ραΦ ςησηγόλοιξΑ ό σιναγρΟ όκϊαπωρυΕ νοτσ ιατνολλάβατακ υοπ ηλέτ ατ ε άκιτεχσ
1) • EMEA budget statement for the financial year 2000, including final appropriations for 1999 and outturn for 1998 (OJ L 184, 24.7.2000, p.
ΕΕ εκηθήιοποπορτ ςωπό ακα ράφ άκιρταινητκ ατ ε άκιτεχσ νώλε L 317 (,
The texts of these and other provisions are available in the series Rules governing medicinal products in the European Community.
νώταρκ νωτ νώισεθο ον νωτ ησιγγέσορπ νητ αιγ
These publications, along with copies of the Official Journal, are available from:
ςωπό ςησυελέορπ ςήκιωζ α ιφόρτ εσ νωκά ραφ νώκιρταινητκ νωπίολατακ νωίρο νωτατώνα ό σιροθακ νοτ,
Office for Official Publications of the European Communities, 2, rue de Mercier, L - 2985 Luxembourg, and also on the EudraLex Internet site at http: / /pharmacos. eudra. org/ eudralex/ index. htm
1)
EMEA documents
ςητ L 214ΕΕ εκηθήιοποπορτ ςωπό νωτνόϊορπ νώκιτυεκα ραφ ησηγόλοιξα νητ αιγ ύο σιναγρο ύοκϊαπωρυε
• First General Report on the Activities of the European Agency for the Evaluation of Medicinal Products 1995 (ISBN 92-827-7491-0, Office for Official Publications of the EU) • Second General Report on the Activities of the European Agency for the Evaluation of Medicinal Products 1996 (ISBN 92-9155-002-7, Office for Official Publications of the EU) • Third General Report on the Activities of the European Agency for the Evaluation of Medicinal Products 1997 (ISBN 92-9155-010-8, Office for Official Publications of the EU) • Fourth General Report on the Activities of the European Agency for the Evaluation of Medicinal Products 1998 (ISBN 92-9155-018-3, Office for Official Publications of the EU) • Fifth General Report on the Activities of the European Agency for the Evaluation of Medicinal Products 1999 (ISBN 92-9155-026-4, EMEA) • Statement of principles governing the partnership between the national competent authorities and the EMEA (EMEA/ MB/ 013/ 97) • Financial Regulation applicable to the budget of the EMEA (EMEA/ MB/ 011/ 97) • Decision of the Executive Director of 3 December 1997 on rules on access to documents of the EMEA (EDIR/ 016/ 1997) • Decision of the Executive Director of 1 June 1999 on cooperation with the European Anti-Fraud Office (OLAF) (EDIR/ 006/ 1999) • Catalogue of EMEA public documents (updated regularly) • EMEA Code of Conduct (EMEA/ D/ 37674/ 99)
νώισακιδαιδ νώκιτονιοκ ησιπσέθ νητ αιγ
These and other documents are available either on the Internet at http: / /www. emea. eu. int or by writing to:
υοτ ίο σιγολοπϋορΠ
Sector for Document management and publishing European Agency for the Evaluation of Medicinal Products 7 Westferry Circus, Canary Wharf London E14 4HB UK
EMEA
63 EMEA General Report 2000
οτ όπα
Annex 2:
1999
EMEA budgets for 1999 to 2001
1999
The summarised comparative budget statements in euro for 1999 to 2001 are given below.
οτ ιρχέ
1999(1)
2000( 2)
2000(2)
2001( 3)
2001(3)
ςενάπα∆
(31.12.1999)
(ςιτσ ιεχέ ςω
(as at 31.12.2000)
20. 12. 2000)
(as at 20.12.2000)
όκιπωσορΠ
Expenditure Staff
ίοθσιΜ
salaries interim and other support persons other staff-related expenditure total title 1
15 074 905
15 074 905 955 456 1 191 570 17 221 931
ίοπιολ ιακ ιοτκατκΈ
36.61% 2.32% 2.89% 41.82%
1 350 000
18 493 000 1 058 000 1 350 000 20 901 000
υοίαλαφεκ ολονύΣ
33.45% 1.91% 2.44% 37.80%
24 652 000
21 772 000 35.15% 1 379 000 2.23% 1 501 000 2.42% 24 652 000 39.80%
39, 80%
Building/ equipment
ςιεσνύραβιπε α ωθσίΜ ςαίσαγρεξεπε ςενάπα∆ νωνέ οδεδ
rent/ charges expenditure on data processing other capital expenditure postage and communications other administrative expenditure
136 038 034 357
2 136 038 1 034 357 1 824 960 370 754 1 194 962
5, 19% 2, 51%
5.19% 2.51% 4.43% 0.90% 2.90%
212 220 423 500
5 212 220 2 423 500 2 353 000 480 000 1 593 000
9, 43% 4, 38%
9.43% 4.38% 4.26% 0.87% 2.88%
5 685 000 1 400 000
5 685 000 9.18% 1 400 000 2.26% 824 500 1.33% 537 000 0.87% 1 784 500 2.88%
9, 18% 2, 26%
total title 2
6 561 071
6 561 071
15, 93%
15.93%
12 061 720
12 061 720 21.82%
10 231 000
10 231 000 16.52%
16, 52%
Operational expenditure
ςιεσάιρδενυΣ ςιεσήγολοιξΑ
meetings
3 274 441 13 894 457
3 274 441
7, 95% 33, 74%
7.95%
3 487 000 18 682 500
3 487 000 6.31%
6 565 000 19 658 000
6 565 000 10.60%
ιολυοβ ύσ ιακ ςετέλεΜ
evaluations translation studies and consultants publications
93 650
13 894 457 93 650 137 130
5 000
-
ςιεσύεισο η∆
33.74% 0.00% 0.23% 0.33%
137 130
18 682 500 p. m.
150 000
5 000 150 000
0, 27%
33.79% 0.00% 0.01% 0.27%
220 000
19 658 000 31.74% 428 000 0.69% 180 000 0.29% 220 000 0.36%
0, 36%
total title 3
17 399 678
17 399 678
42, 25%
42.25%
22 324 500
22 324 500 40.38%
27 051 000
27 051 000 43.68%
Ν ΝΑΠΑ∆ ΟΛΟΝΥΣ αδοσΈ
TOTAL EXPENDITURE
41 182 680 100, 00%
41 182 680 100.00%
61 934 000
61 934 000 100.00%
100, 00%
Revenue
ΕΕ ςητ άροφσιενυσ ήκινεΓ ΕΕ ςητ άροφσιενυσ ήκιδιΕ
fees general EU contribution special EU orphan medicinal
10 481 649
28 952 500 70.31% 10 481 649 25.45%
200 000
39 154 000 70.82% 13 200 000 23.88%
14 700 000
42 610 000 68.81% 14 700 000 23.73%
ακα ράφ άναφρο ατ ΧΟΕ υοτ άροφσιενυΣ
product contribution contribution from EEA contribution from EU
0, 00% 0, 00%
-- 0.00% -- 0.00%
000 000 245 220
1 000 000 1.81% 245 220 0.44%
600 000 250 000
600 000 0.97% 250 000 0.40%
(PERF)
programmes (PERF) other
800 000
800 000 1.94% 948 531 2.30%
217 000
217 000 0.39% 1 471 000 2.66%
2 440 000
2 440 000 3.94% 1 334 000 2.15%
άπιοΛ
TOTAL REVENUE
41 182 680
41 182 680 100.00%
55 287 220 100, 00%
55 287 220 100.00%
1999:
Notes
ςό σιγολοπϋορΠ (3)
(1) 1999 budget: outturn figures.
. ςιεσώτσιπ ςέκιλετ
(2) 2000 budget: final appropriations.
. νωεσώτσιπ οιδέχσ
(3) 2001 budget: draft appropriations.
ησεθκέ αισήτΕ
64 EMEA General Report 2000
68/ 97
Annex 3:
α ητράραΠ υοίλυοβ υσ ύοκιτηκιοιδ υοτ ηλέΜ
Members of the Management Board
ςορδεόρΠ
Chairman
André BROEKMANS 1
André BROEKMANS 1
ηλέΜ
Members
οιλύοβονιοΚ όκϊαπωρυΕ
European Parliament
Gianmartino BENZI, José- Luis VALVERDE LÓPEZ2 ηλέ άκιτα ωρηλπανΑ:
Gianmartino BENZI, José-Luis VALVERDE LÓPEZ 2 Alternates:
Fabio COLASANTI3, Bertrand CARSIN4 ςολέ όκιτα ωρηλπανΑ:
European Commission Fabio COLASANTI 3, Bertrand CARSIN 4 Alternates:
Belgique/ België Danmark Deutschland
Paul WEISSENBERG Belgique/ België Danmark Deutschland
André PAUWELS, Frans GOSSELINCKX Ib VALSBORG, Jytte LYNGVIG5 Hermann Josef PABEL, Gerhard Josef KOTHMANN, Vice- chairman 6 7
André PAUWELS, Frans GOSSELINCKX Ib VALSBORG, Jytte LYNGVIG 5 Hermann Josef PABEL, Gerhard Josef KOTHMANN, (Vice-chairman)
αδάλλΕ / Greece
Eλλ δα / Greece España
, ΣΟΛΑΙΣΣΟΜ ςαίλΗ ΣΟΛΕΣΡΑΜ ςοιράΜ
Marios MARSELOS 6, Elias MOSSIALOS 7 María Victoria de la CUESTA GARCIA 8, Ramón PALOP BAIXAULI 9
España France Ireland Italia Luxembourg Nederland Österreich Portugal Suomi/ Finland Sverige United Kingdom
France Ireland Italia Luxembourg Nederlands Österreich Portugal Suomi/ Finland Sverige United Kingdom
María Victoria de la CUESTA GARCIA8, Ramón PALOP BAIXAULI9 Philippe DUNETON, Martin HIRSCH10 Tom MOONEY, Colm GAYNOR11 Nello MARTINI, Romano MARABELLI Mariette BACKES- LIES John LISMAN12, Frits PLUIMERS Alexander JENTZSCH, Ernst LUSZCZAK Miguel ANDRADE13, Rógerio GASPAR14 Pekka JÄRVINEN15, Hannes WAHLROOS Birgitta BRATTHALL, Anders BROSTRÖM Keith JONES, Michael RUTTER
Philippe DUNETON, Martin HIRSCH 10 Tom MOONEY, Colm GAYNOR 11 Nello MARTINI, Romano MARABELLI Mariette BACKES-LIES John LISMAN 12, Frits PLUIMERS Alexander JENTZSCH, Ernst LUSZCZAK Miguel ANDRADE 13, Rógerio GASPAR 14 Pekka JÄRVINEN 15, Hannes WAHLROOS Birgitta BRATTHALL, Anders BROSTRÖM Keith JONES, Michael RUTTER
ςέτηρηταραΠ
Observers
Ísland Liechtenstein Norge/ Noreg
Ísland
Rannveig GUNNARSDÓTTIR, Ingolf PETERSEN Brigitte BATLINER, Peter MALIN Andreas DISEN, Gro Ramsten WESENBERG
Rannveig GUNNARSDÓTTIR, Ingolf PETERSEN
νοτ εσητσέτακιτνα
Liechtenstein Norge/ Noreg
υοίραυορβεΦ ςα ςητ ησαίρδενυσ ητ όπΑ
Brigitte BATLINER, Peter MALIN Andreas DISEN, Gro Ramsten WESENBERG
Dietrich HENSCHLER.
1 Resigned at the 20 December 2000 meeting.
νοτ εσητσέτακιτνα
2 Replaced Dietrich HENSCHLER as of the 22 February 2000 meeting.
νοτ εσητσέτακιτνα
3 Replaced Jörn KECK as of the 22 February 2000 meeting.
υοίραυορβεΦ ςςα ςητ ησαίρδενυσ ητ όπΑ Joachim HEINE.
4 Replaced Joachim HEINE as of the 22 February 2000 meeting.
Ib Bo LUMHOLTZ.
5 Replaced Ib Bo LUMHOLTZ as of the 23 October 2000 meeting.
ΟΛΥΟΠΟΣΤΥΟΜ οπ αλάραΧ νοτ εσητσέτακιτνα
6 Replaced Haralampos MOUTSOPOULOS as of the 20 December 2000 meeting.
Ψ ηννάωΙ νοτ εσητσέτακιτνα
7 Replaced John PSOMAS as of the 20 December 2000 meeting.
Maria Teresa PAGÉS JIMÉNEZ.
8 Replaced María Theresa PAGÉS JIMÉNEZ as of the 20 December 2000 meeting.
Mariano BITRIAN CALVO.
9 Replaced Mariano BITRIÁN CALVO as of the 20 December 2000 meeting.
10
10 Replaced Jacques BOISSEAU as of the 22 February 2000 meeting.
11
11 Replaced John COSTELLOE as of the 22 February 2000 meeting.
12
12 Replaced André BROEKMANS as of the 7 June 2000 meeting.
13
13 Replaced José António ARANDA da SILVA as of the 22 February 2000 meeting.
14
14 Replaced Maria Armanda MIRANDA as of the 22 February 2000 meeting.
15
15 Replaced Kimmo LEPPO as of the 22 February 2000 meeting.
ησεθκέ αισήτΕ
65 EMEA General Report 2000
4
Annex 4:
νωτά σαυεκσοιδΙ νώκιτυεκα ραΦ ςήπορτιπΕ ςητ ηλέΜ
Members of the Committee for Proprietary Medicinal Products1
Jean- Michel ALEXANDRE (France),
· Jean-Michel ALEXANDRE (France), Chairman
Eric ABADIE (France) Mark AINSWORTH (Danmark) 17 Fernando de ANDRÉS- TRELLÉS (España) Cristina AVENDAÑO (España) (αδάλλΕ ΣΟΝΙΡΕΓΥΑ ςηλάχιΜ / Greece) 18
• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Hans van BRONSWIJK (Nederland), Geert DE GREEF (Belgique/ België) Jens ERSBØLL (Danmark) Silvio GARATTINI (Italia) Jacqueline GENOUX- HAMES (Luxembourg) Willem van der GIESEN (Nederland) Lars GRAMSTAD (Norge/ Noreg) Manfred HAASE (Deutschland) Magnús JÓHANNSSON (Ísland) Tove KARLSUD (Norge/ Noreg) Pekka KURKI (Suomi/ Finland) 20 David LYONS (Ireland) Jose Guimarães MORAIS (Portugal) 21 Per NILSSON (Sverige) Jean- Louis ROBERT (Luxembourg) Frances ROTBLAT (United Kingdom) 22 Patrick SALMON (Ireland) 23 Tomas SALMONSON (Sverige) Cristina SAMPAIO (Portugal) Sigurdur THORSTEINSSON (Ísland) Markku TOIVONEN (Suomi/ Finland) Jean- Hugues TROUVIN (France) Guiseppe VICARI (Italia) Patrick WALLER (United Kingdom) Hans WINKLER (Österreich) Christa WIRTHUMER- HOCHE (Österreich) (αδάλλΕ ΗΚΑΤ ΙΓ αίλυοΙ / Greece)
· Eric ABADIE (France) · Mark AINSWORTH (Danmark) 2 · Fernando de ANDRES-TRELLES (España) · Cristina AVENDAÑO (España) · Michalis AVGERINOS (Eλλ δα/Greece) · Rolf BASS (Deutschland) 3 · Daniel BRASSEUR (Belgique/België) · Hans van BRONSWIJK (Nederlands), Vice-chairman 4 · Geert DE GREEF (Belgique/België) · Jens ERSBØLL (Danmark) · Silvio GARATTINI (Italia) · Jacqueline GENOUX-HAMES (Luxembourg) · Willem van der GIESEN (Nederlands) · Lars GRAMSTAD (Norge/Noreg) · Manfred HAASE (Deutschland) · Magnús JÓHANNSSON (Ísland) · Tove KARLSUD (Norge/Noreg) · Pekka KURKI (Suomi/Finland) 5 · David LYONS (Ireland) · Jose Guimarães MORAIS (Portugal) 6 · Per NILSSON (Sverige) · Jean-Louis ROBERT (Luxembourg) · Frances ROTBLAT (United Kingdom) 7 · Patrick SALMON (Ireland) 8 · Tomas SALMONSON (Sverige) · Cristina SAMPAIO (Portugal) · Sigurdur THORSTEINSSON (Ísland) · Markku TOIVONEN (Suomi/Finland) · Jean-Hugues TROUVIN (France) · Guiseppe VICARI (Italia) · Patrick WALLER (United Kingdom) · Hans WINKLER (Österreich) · Christa WIRTHUMER-HOCHE (Österreich) · Julia YOTAKI (Eλλ δα/Greece)
ςορδεόρπιτνΑ
1 2 3 4 5 6 7 8
υοίραυοναΙ υοτ ησαίρδενυσ ητ όπΑ 2000
The country of the nominating Member State is given for information purposes only.
νοτ εσητσέτακιτνα Gorm JENSEN.
Replaced Gorm JENSEN as of the January 2000 meeting.
Alfred HILDEBRANDT
Replaced Alfred HILDEBRANDT as of the September 2000 meeting.
υοίρβ ετπεΣ υοτ ησαίρδενυσ ητ όπΑ 2000
Replaced Mary TEELING as Vice-chairman as of the September 2000 meeting.
Eva ALHAVA.
Replaced Eva ALHAVA as of the March 2000 meeting.
νοτ εσητσέτακιτνα Rogerio GASPAR.
Replaced Rogério GASPAR as of the January 2000 meeting.
David JEFFERYS. νοτ εσητσέτακιτνα
Replaced David JEFFERYS as of the March 2000 meeting.
Mary TEELING.
Replaced Mary TEELING as of the September 2000 meeting.
α ητράραΠ
66 EMEA General Report 2000
70/ 97
Annex 5:
24 νωτνόϊορΠ νώκιτυεκα ραΦ νώκιρταινητΚ ςήπορτιπΕ ςητ ηλέΜ
Members of the Committee for Veterinary Medicinal Products1
Reinhard KROKER (Deutschland),
Reinhard KROKER (Deutschland), Chairman
ςορδεόρΠ
• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Margarita ARBOIX (España)
Margarita ARBOIX (España) J.
Françoise FALIZE (Belgique/ België) Christian FRIIS (Danmark) Helle HARTMANN FRIES (Danmark) Johannes HOOGLAND (Nederland) Tonje HØY (Norge/ Noreg) Albert HUBERTY (Luxembourg) Eva FABIANSON- JOHNSSON (Sverige) 25 Liisa KAARTINEN (Suomi/ Finland) Herman LENSING (Nederland) Jan LUTHMAN (Sverige) Agostino MACRI (Italia) (αδάλλΕ ΣΗΜΕΛΑΜ ςηννάωΙ / Greece)
Gabriel BEECHINOR (Ireland), Vice-chairman Hanne BERGENDAHL (Norge/Noreg) Rory BREATHNACH (Ireland) Gabriella CONTI (Italia) Luis CORBALAN (España) Steve DEAN (United Kingdom) Johannes DICHTL (Österreich) Sabine EGLIT (Deutschland) Françoise FALIZE (Belgique/België) Christian FRIIS (Danmark) Helle HARTMANN FRIES (Danmark) Johannes HOOGLAND (Nederlands) Tonje HØY (Norge/Noreg) Albert HUBERTY (Luxembourg) Eva FABIANSON-JOHNSSON (Sverige) 2 Liisa KAARTINEN (Suomi/Finland) Herman LENSING (Nederlands) Jan LUTHMAN (Sverige) Agostino MACRI (Italia) Ioannis MALEMIS (Eλλ δα/Greece) Maria Leonor MEISEL (Portugal) 3 Manfred MOOS (Deutschland) Gérard MOULIN (France) John O’BRIEN (United Kingdom) Eugen OBERMAYR (Österreich) Sigurdur ÖRN HANSSON (Ísland) Orestis PAPADOPOULOS (Eλλ δα/Greece) 4 Paul-Pierre PASTORET (Belgique/België) Margarida PRATAS (Portugal) Halldór RUNÓLFSSON (Ísland) Jean-Claude ROUBY (France) Liisa SIHVONEN (Suomi/Finland) Marc WIRTOR (Luxembourg)
·
1 2 3 4
αδάλλΕ ΣΟΛΥΟΠΟ∆ΑΠΑΠ ςητσέρΟ (
The country of the nominating Member State is given for information purposes only.
Annika WENNBERG.
Replaced Annika WENNBERG as of the October 2000 meeting.
Carlos SINOGAS.
Replaced Carlos SINOGAS as of the July 2000 meeting.
EMEA/ MB/ 050/ 00 2000 ησεθκέ αισήτΕ
Replaced Christos HIMONAS as of the April 2000 meeting.
α ητράραΠ
67 EMEA General Report 2000
71/ 97
Annex 6:
ακα ράφ άναφρο ατ αιγ ςήπορτιπε ςητ ηλέΜ ςορδεόρΠ
Members of the Committee for Orphan Medicinal Products
España
Chairman (España)
αδάλλΕ / Greec France Ireland Italia Luxembourg Nederland Österreich
Belgique/België Danmark Deutschland Eλλ δα/Greece France Ireland Italia Luxembourg Nederlands Österreich Portugal Suomi/Finland Sverige United Kingdom Patient organisation
ΣΟΛΥΟΠΟΘΑΡΤΣ ςοιγρώεΓ François MEYER Brendan BUCKLEY Domenica TARUSCIO Henri METZ30 Harrie SEEVERENS Hans Georg EICHLER
André LHOIR Jan RENNEBERG Rembert ELBERS 1 George STRATHOPOULOS 2 François MEYER Brendan BUCKLEY Domenica TARUSCIO Henri METZ 3 Harrie SEEVERENS Hans Georg EICHLER José Manuel Gião TOSCANO RICO Kalle HOPPU Kerstin WESTERMARK Rashmi SHAH
Portugal Suomi/ Finland Sverige United Kingdom
representatives
Moisés ABASCAL ALONSO32 Yann LE CAM, 32 ςορδεόρπιτνΑ Alastair KENT33
Moisés ABASCAL ALONSO 5 Yann LE CAM, 5 Vice-chairman Alastair KENT 6
ΑΕΜΕ υοτ ιοπωσόρπκΕ
EMEA representatives
Jean- Michel ALEXANDRE34 Gianmartino BENZI Mary TEELING35
Jean-Michel ALEXANDRE 7 Gianmartino BENZI Mary TEELING 8
Ísland Norge/ Noreg
Ísland Norge/Noreg
Sigurdur THORSTEINSSON Randi NORDAL
Sigurdur THORSTEINSSON Randi NORDAL
Tilman OTT.
1 2 3 4 5 6 7 8
υοίρβ ετπεΣ υοτ ησαίρδενυσ ητ όπΑ 29 2000 30
Replaced Tilman OTT as of the September 2000 meeting.
υοίρβωτκΟ υοτ ησαίρδενυσ ητ όπΑ
Replaced Thrassyvoulos KEPHALAS as of the October 2000 meeting.
Mariette BACKES LIES. ησαίρδενυσ ητ όπΑ
Replaced Mariette BACKES LIES as of the November 2000 meeting.
Alexander NICHOLSON.
Replaced Alexander NICHOLSON as of the June 2000 meeting.
υοίνυοΙ υοτ ησαίρδενυσ ητ όπΑ 32 (Eurodis). ακα ράΦ άναφρΟ ατ αιγ ςησωνΈ ςήκϊαπωρυΕ ςητ ςοπωσόρπκΕ 33 EAGS (European Alliance of Genetic Support Groups). ςητ ςοπωσόρπκΕ 34 2000. υοίρβ εκε∆ υοτ ησαίρδενυσ ητ άτακ εκηθήτιαραΠ 35 2000. υοίρβ ετπεΣ υοτ ησαίρδενυσ ητ άτακ εκηθήτιαραΠ EMEA/ MB/ 050/ 00 2000 ησεθκέ αισήτΕ
Representing the European Alliance of Genetic Support Groups (EAGS).
α ητράραΠ
Resigned as of the December 2000 meeting.
αδίλεΣ
68 EMEA General Report 2000
72/ 97
Annex 7:
νώχρα νωίδο ρα νώκινθε νωτ ιοπωσόρπκΕ
National competent authority partners
νωτ ςιεσέθ ςιτσ ςησίπε ιατνεθίταιδ ςέχρα ςειδό ρα ςέκινθε ςιτ ε άκιτεχσ ςείροφορηλπ ςερετόσσιρεΠ: http: // heads. medagencies. org and http: // www. hevra. org ουτκίδαι∆ οτσ νώχρα νωίδο ρα νώκινθε
Further information on the national competent authorities is also available on the national authorities’ Internet sites: http://heads.medagencies.org and http://www.hevra.org
BELGIQUE/ BELGÏE André PAUWELS Conseiller Général / Generaal Adviseur Ministère des affaires sociales, de la santé publique et de l’ environnement Inspection Générale de la Pharmacie Ministerie van Sociale Zaken, Volksgezondheid en Leefmilieu Algemeine Farmaceutische Inspektie Boulevard Bisschoffsheim / Bisschoffsheimlaan, 33 B – 1000 Bruxelles / Brussel Τ él. / Tel.
BELGIQUE/BELGÏE André PAUWELS Conseiller Général/ Generaal Adviseur Ministère des affaires sociales, de la santé publique et de l’environnement Inspection Générale de la Pharmacie Ministerie van Sociale Zaken, Volksgezondheid en Leefmilieu Algemeine Farmaceutische Inspektie Boulevard Bisschoffsheim / Bisschoffsheimlaan, 33 B – 1000 Bruxelles / Brussel Tel.
(32- 2) 227 55 67 Fax (32- 2) 227 55 55/ 56 39 E- mail: andre. pauwels@ afigp. fgov. be Internet: http: // www. afigp. fogv. be
(32-2) 227 55 67 Fax (32-2) 227 55 55/56 39 E-mail: andre.pauwels@afigp.fgov.be Internet: http://www.afigp.fogv.be
Jytte LYNGVIG Direktør Lægemiddelstyrelsen Frederikssundsvej 378 DK – 2700 Brønshøj Tlf.
DANMARK Jytte LYNGVIG Direktør Lægemiddelstyrelsen Frederikssundsvej 378 DK – 2700 Brønshøj Tel.
(45) 44 88 93 34 Fax (45) 44 88 91 09 E- post: jyl@ dkma. dk Internet: http: // www. dkma. dk
(45) 44 88 93 34 Fax (45) 44 88 91 09 E-mail: jyl@dkma.dk Internet: http://www.dkma.dk
D – 53113 Bonn Tel.
DEUTSCHLAND Harald SCHWEIM Direktor BfArM Friedrich-Ebert-Allee 38 D – 53113 Bonn Tel.
(49- 22) 82 07 32 03
(49-22) 82 07 32 03 Fax (49-30) 87 07 55 14 E-mail: schweim@bfarm.de Internet: http://www.bfarm.de
Diedersdorfer Weg, 1 D – 12277 Berlin
Reinhard KROKER Leiter des Fachbereiches ‘Tierarzneimittelzulassung und -rückstandskontrolle, Futterzusatzstoffe’ BgVV Diedersdorfer Weg, 1 D – 12277 Berlin Tel.
Fax (49- 30) 84 12 29 65 E- mail: r. kroker@ bgvv. de
(49-30) 84 12 23 64 Fax (49-30) 84 12 29 65 E-mail: r.kroker@bgvv.de
Johannes LÖWER Kommissarische Leiter Paul- Ehrlich Institut Paul- Ehrlich Straße 51- 59 D – 63225 Langen Tel.
Johannes LÖW ER Kommissarische Leiter Paul-Ehrlich Institut Paul-Ehrlich Straße 51-59 D – 63225 Langen Tel.
(49- 6103) 77 20 01 Fax (49- 6103) 77 12 52 E- Mail: loejo@ pei. de Internet: http: // www. pei. de
(49-6103) 77 20 01 Fax (49-6103) 77 12 52 E-mail: loejo@pei.de Internet: http://www.pei.de
αδάλλΕ
Internet: http://www.bgvv.de
/ GREECE
69 EMEA General Report 2000
Marios MARSELOS President National Organization for Medicines Mesogion 284 GR – 155 62 Holargos Athens Tel.
Eλλ δα/GREECE Marios MARSELOS President National Organization for Medicines Mesogion 284 GR – 155 62 Holargos Athens Tel.
(30- 1) 650 72 10 Fax (30- 1) 654 95 86 E- mail: hmoutsop@ eof. gr
(30-1) 650 72 10 Fax (30-1) 654 95 86 E-mail: hmoutsop@eof.gr
María Victoria de la CUESTA GARCIA Directora Agencia Española del Medicamento Ministerio de Sanidad y Consumo C/ Huertas 75 E – 28014 Madrid Tel.
ESPAÑA María Victoria de la CUESTA GARCIA Directora Agencia Española del Medicamento Ministerio de Sanidad y Consumo C/Huertas 75 E – 28014 Madrid Tel.
(34- 91) 596 16 27 Fax (34- 91) 596 16 15 E- mail: sdaem@ agamed. es Internet: http: // www. agamed. es
(34-91) 596 16 27 Fax (34-91) 596 16 15 E-mail: sdaem@agamed.es Internet: http://www.agamed.es
Philippe DUNETON Directeur- Général Agence française de sécurité sanitaire des produits de santé 143- 147, blvd Anatole France F – 93200 Saint- Denis CEDEX Tél.
Philippe DUNETON Directeur-Général Agence Française de Sécurité Sanitaire des Produits de Santé 143-147, blvd Anatole France F - 93200 Saint-Denis CEDEX Tel.
(33- 1) 55 87 30 14 Fax (33- 1) 55 87 30 12 E- mail: philippe. duneton@ afssaps. sante. fr Internet: http: // agmed. sante. gouv. fr Internet: http: // www. afssa. fr
(33-1) 55 87 30 14 Fax (33-1) 55 87 30 12 E-mail: philippe.duneton@afssaps.sante.fr Internet: http://agmed.sante.gouv.fr
Martin HIRSCH Directeur- Général Agence Française de Sécurité Sanitaire des aliments 23, avenue du Général de Gaulle B. P.
Martin HIRSCH Directeur-Général Agence Française de Sécurité Sanitaire des aliments 23, avenue du Général de Gaulle B.P.
19 F – 94701 Maisons Alfort CEDEX Tel.
19 F – 94701 Maisons Alfort CEDEX Tel.
(33- 1) 49 77 13 99/ 26 54 Fax (33- 1) 49 77 26 26 E- mail: m. hirsch@ dg. afssa. fr
(33-1) 49 77 13 99/26 54 Fax (33-1) 49 77 26 26 E-mail: m.hirsch@dg.afssa.fr Internet: http://www.afssa.fr
Frank HALLINAN Chief Executive Officer Irish Medicines Board The Earlsfort Centre Earlsfort Terrace Dublin 2 Ireland Tel.
Frank HALLINAN Chief Executive Officer Irish Medicines Board The Earlsfort Centre Earlsfort Terrace Dublin 2 Tel.
(353- 1) 676 49 71 Fax (353- 1) 676 78 36 E- mail: frank. hallinan@ imb. ie Internet: http: // www. imb. ie
(353-1) 676 49 71 Fax (353-1) 676 78 36 E-mail: frank.hallinan@imb.ie Internet: http://www.imb.ie
Seamus HEALY Assistant Secretary Department of Agriculture, Food and Forestry Agriculture House Kildare Street Dublin 2 Ireland Tel.
Seamus HEALY Assistant Secretary Department of Agriculture, Food and Forestry Agriculture House Kildare Street Dublin 2 Tel.
(353- 1) 607 24 34 Fax (353- 1) 676 29 89 E- mail: seamus. healy@ daff. irlgov. ie
(353-1) 607 24 34 Fax (353-1) 676 29 89 E-mail: seamus.healy@daff.irlgov.ie
ITALIA
ITALIA
Nello MARTINI Direttore Generale del Dipartimento per Valutazione dei medicinale e la farmacovigilanza Ministero della Sanità Viale Civilità Romana 7 I – 00144 Roma Tel.
Nello MARTINI Direttore Generale del Dipartimento per Valutazione dei medicinale e la farmacovigilanza Ministero della Sanità Viale Civilità Romana 7 I -00144 Roma Tel.
(39- 6) 59 94 36 66 Fax (39- 6) 59 94 34 56 E- mail: farmaci. sanita@ interbusiness. it Internet: http: // www. sanita. it/ farmaci
(39-6) 59 94 36 66 Fax (39-6) 59 94 34 56 E-mail: farmaci.sanita@interbusiness.it Internet: http://www.sanita.it/farmaci